EdgarLookup
3

FORM 3

Company
ROCKET PHARMACEUTICALS, INC.
Filed
March 11, 2022
Period of Report
March 10, 2022
Accession Number
0001140361-22-009220
View Document ↗ View on SEC.gov ↗